Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies

Atherosclerosis

Volumn 232, Issue 2, 2014, Pages 265-270

  Li, Min ^a   Hou, Wenshang ^a   Zhang, Xiaowei ^a   Hu, Liqin ^a   Tang, Zhenyu ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Hyperuricemia; Incidence; Meta analysis; Mortality; Stroke

Indexed keywords

URIC ACID;

ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; INCIDENCE; MORTALITY; OBESITY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; URIC ACID BLOOD LEVEL;

HYPERURICEMIA; INCIDENCE; META-ANALYSIS; MORTALITY; STROKE;

FEMALE; HUMANS; HYPERURICEMIA; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; STROKE;

EID: 84892837210     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.051     Document Type: Review

References (49)

1. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
2. WHO The global burden of disease: 2004 update 2008, WHO, Geneva, Switzerland.
3. WHO World Health Organisation: the 10 leading causes of death by broad income group 2008, World health organisation website:, [accessed August 2012]. http://www.who.int/mediacentre/factsheets/fs310/en/.
4. Strong K., Mathers C., Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007, 6:182-187.
5. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
6. Sidney S., Rosamond W.D., Howard V.J., Luepker R.V. The "heart disease and stroke statistics-2013 update" and the need for a national cardiovascular surveillance system. Circulation 2013, 127:21-23.
7. Becker B.F. Towards the physiological function of uric acid. Free Radic Biol Med 1993, 14:615-631.
8. Sinha S., Singh S.N., Ray U.S. Total antioxidant status at high altitude in lowlanders and native highlanders: role of uric acid. High Alt Med Biol 2009, 10:269-274.
9. Becker M.A., Schumacher H.R., Wortmann R.L., et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. NEngl J Med 2005, 353:2450-2461.
10. Yu Z.F., Bruce-Keller A.J., Goodman Y., Mattson M.P. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury invivo. JNeurosci Res 1998, 53:613-625.
11. Chamorro A., Obach V., Cervera A., Revilla M., Deulofeu R., Aponte J.H. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 2002, 33:1048-1052.
12. Johnson R.J., Kang D.H., Feig D., et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease. Hypertension 2003, 41:1183-1190.
13. Nakanishi N., Okamoto M., Yoshida H., Matsuo Y., Suzuki K., Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003, 18:523-530.
14. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. NEngl J Med 2008, 359:1811-1821.
15. Lehto S., Niskanen L., Ronnemaa T., Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998, 29:635-639.
16. Chien K.L., Hsu H.C., Sung F.C., Su T.C., Chen M.F., Lee Y.T. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005, 183:147-155.
17. Bos M.J., Koudstaal P.J., Hofman A., Witteman J.C., Breteler M.M. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37:1503-1507.
18. Hozawa A., Folsom A.R., Ibrahim H., Nieto F.J., Rosamond W.D., Shahar E. Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis 2006, 187:401-407.
19. Koton S., Howard S.C., Warlow C.P., Murphy M.F., Rothwell P.M. Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke. Cerebrovasc Dis 2008, 26:517-524.
20. Sakata K., Hashimoto T., Ueshima H., Okayama A. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National integrated projects for prospective observation of non-communicable diseases and its trend in the aged. Eur J Epidemiol 2001, 17:461-468.
21. Mazza A., Pessina A.C., Pavei A., Scarpa R., Tikhonoff V., Casiglia E. Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol 2001, 17:1097-1104.
22. Jee S.H., Lee S.Y., Kim M.T. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil 2004, 11:185-191.
23. Gerber Y., Tanne D., Medalie J.H., Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil 2006, 13:193-198.
24. Strasak A., Ruttmann E., Brant L., et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 2008, 54:273-284.
25. Strasak A.M., Kelleher C.C., Brant L.J., et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008, 125:232-239.
26. Chen J.H., Chuang S.Y., Chen H.J., Yeh W.T., Pan W.H. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009, 61:225-232.
27. Holme I., Aastveit A.H., Hammar N., Jungner I., Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). JIntern Med 2009, 266:558-570.
28. Kuo C.F., See L.C., Yu K.H., Chou I.J., Chiou M.J., Luo S.F. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 2013, 52:127-134.
29. Kanellis J., Johnson R.J. Editorial comment - elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotective. Stroke 2003, 34:1956-1957.
30. Weir C.J., Muir S.W., Walters M.R., Lees K.R. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003, 34:1951-1956.
31. Kim S.Y., Guevara J.P., Kim K.M., Choi H.K., Heitjan D.F., Albert D.A. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 2009, 61:885-892.
32. Wells G.A., Shea B., O'Connell D., Petersen J., Welch V. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses Available:, [accessed 31.03.12]. http://www,ohri.ca/programs/clinical_epidemiology/oxford.htm.
33. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
34. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
35. Higgins J.P.T., Green S. Cochrane handbook for systematic reviews of interventions 2008, The Cochrane Collaboration, Oxford, UK.
36. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
37. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007, 6:149-161.
38. Meschia J.F., Worrall B.B., Rich S.S. Genetic susceptibility to ischemic stroke. Nat Rev Neurol 2011, 7:369-378.
39. Humphries S.E., Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004, 3:227-235.
40. Modan M., Halkin H., Karasik A., Lusky A. Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 1987, 30:713-718.
41. Lee J., Sparrow D., Vokonas P.S., Landsberg L., Weiss S.T. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995, 142:288-294.
42. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAm Med Assoc 2000, 283:2404-2410.
43. Nakanishi N., Tatara K., Nakamura K., Suzuki K. Risk factors for the incidence of hyperuricaemia: a 6-year longitudinal study of middle-aged Japanese men. Int J Epidemiol 1999, 28:888-893.
44. Klein R., Klein B.E., Cornoni J.C., Maready J., Cassel J.C., Tyroler H.A. Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973, 132:401-410.
45. Bengtsson C., Lapidus L., Stendahl C., Waldenstrom J. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988, 224:549-555.
46. Suarna C., Dean R.T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 1995, 15:1616-1624.
47. Nieto F.J., Iribarren C., Gross M.D., Comstock G.W., Cutler R.G. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis. Atherosclerosis 2000, 148:131-139.
48. Steinberg H.O., Brechtel G., Johnson A., Fineberg N., Baron A.D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. JClin Invest 1994, 94:1172-1179.
49. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.